| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $72.1M | +54.7% |
| SG&A Expense | $42.3M | -16.0% |
| Operating Income | -$123.8M | -27.8% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$132.4M | -39.4% |
| Income Tax | $0 | — |
| Net Income | -$132.4M | -39.4% |
| EPS (Basic) | -$0.95 | +20.2% |
| EPS (Diluted) | -$0.95 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.3M | +135.6% |
| Current Assets | $358.2M | -24.9% |
| Total Assets | $391.5M | -22.2% |
| Current Liabilities | $15.7M | +36.2% |
| Total Liabilities | $32.8M | +25.1% |
| Stockholders' Equity | $358.7M | -24.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$90.6M | -35.5% |
| Capital Expenditures | $10.7M | +86.4% |
| Investing Cash Flow | $137.2M | +130.4% |
| Financing Cash Flow | $1.9M | -99.6% |
| Free Cash Flow | -$101.3M | -39.6% |
| +20.2% |